BTSG BRIGHTSPRING HEALTH SERVICES INC.

BrightSpring Health Services, Inc. to Announce First Quarter 2024 Financial Results on May 2, 2024, and Participate in the Bank of America 2024 Healthcare Conference

BrightSpring Health Services, Inc. to Announce First Quarter 2024 Financial Results on May 2, 2024, and Participate in the Bank of America 2024 Healthcare Conference

LOUISVILLE, Ky., April 09, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its first quarter 2024 financial results on Thursday, May 2, 2024, prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day.

To participate in the conference call, please register before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company’s investor relations website at under the “Events & Presentations” section, where related presentation materials will be posted prior to the conference call. The webcast may be accessed directly .

BrightSpring will also participate at the upcoming Bank of America 2024 Health Care Conference. Company management will present on Wednesday, May 15, at 9:20 a.m. PT. A live and archived webcast of the presentation will be available on the “Event & Presentations” section of the BrightSpring investor relations website at .

About BrightSpring Health Services

BrightSpring Health Services is the parent company of leading healthcare service lines that provide complementary home- and community-based pharmacy and provider health solutions for complex populations in need of specialized and/or chronic care. Through the company’s high-quality and impactful pharmacy, primary care and home health care, and rehabilitation and behavioral health services, and through its skilled and dedicated employees, we provide comprehensive care and clinical solutions in all 50 states to over 400,000 customers, clients and patients daily. For more information, visit .

Contact

Investor Relations:

David Deuchler, CFA

Gilmartin Group LLC



Media Contact:

Leigh White



502.630.7412

 



EN
09/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on BRIGHTSPRING HEALTH SERVICES INC.

 PRESS RELEASE

BrightSpring Health Services, Inc. Reports First Quarter 2024 Financia...

BrightSpring Health Services, Inc. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Guidance LOUISVILLE, Ky., May 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the first quarter ended March 31, 2024, and increases 2024 revenue and Adjusted EBITDA1 guidance. Financial Highlights Net Revenue of $2,577 million, up 27.0%...

 PRESS RELEASE

BrightSpring Health Services, Inc. Welcomes Timothy A. Wicks to Board ...

BrightSpring Health Services, Inc. Welcomes Timothy A. Wicks to Board of Directors LOUISVILLE, Ky., April 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced that on April 24, 2024, BrightSpring appointed Timothy A. Wicks as a new member of the Board of Directors. Mr. Wicks will assume his new role effective immediately, bringing the Company’s total Board of Directors to seven members, including two independent directors. Mr...

 PRESS RELEASE

BrightSpring Health Services Specialty Pharmacy Onco360® Selected as N...

BrightSpring Health Services Specialty Pharmacy Onco360® Selected as National Pharmacy Partner for Voydeya® LOUISVILLE, Ky., April 10, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) announced today that its company Onco360®, a leading independent oncology pharmacy, was selected as a national pharmacy partner by Alexion Pharmaceuticals for a first-in-class, oral, Factor D inhibitor, Voydeya® (Danicopan) to treat patients with a rare, life-threatening disease of the blood called paroxysmal nocturnal hemoglobinuria (PNH...

 PRESS RELEASE

BrightSpring Health Services, Inc. to Announce First Quarter 2024 Fina...

BrightSpring Health Services, Inc. to Announce First Quarter 2024 Financial Results on May 2, 2024, and Participate in the Bank of America 2024 Healthcare Conference LOUISVILLE, Ky., April 09, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its first quarter 2024 financial results on Thursday, May 2, 2024, prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register before the 8:30 a.m. ET sta...

 PRESS RELEASE

BrightSpring Health Services Applauds Hundreds of Award-Winning Employ...

BrightSpring Health Services Applauds Hundreds of Award-Winning Employees for their Recognition of Outstanding Service and Care LOUISVILLE, Ky., April 04, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or “the Company”) (NASDAQ: BTSG) applauds its most recent employees and programs for their dedicated service, care, and innovation, which has resulted in ongoing and additional national recognition by industry publications and trade associations. Since 2017, over 200 of BrightSpring’s individual employees have now been recognized for their award-winning leade...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch